https://www.ibtomato.com/ExternalView.aspx?type=1&no=19981IB토마토ko2026-10-30T10:53:38+09:00(럭셔리의 비극)④펀드도 전환도 높은 벽…하이엔드 PF 출구 실종https://www.ibtomato.com/ExternalView.aspx?type=1&no=19978IB토마토ko2026-10-30T10:03:41+09:00철강업계, 본업 그대로여도 영업익 '뚝'…IFRS18이 바꿀 숫자https://www.ibtomato.com/ExternalView.aspx?type=1&no=19973IB토마토ko2026-10-29T18:09:24+09:00더존비즈온, 춘천 개발 출자 미루고…346억은 대여금으로https://www.ibtomato.com/ExternalView.aspx?type=1&no=19976IB토마토ko2026-10-29T17:37:25+09:00(전기차 지원의 역설)③세금 깎아줘도…웃지 못하는 중견 3사https://www.ibtomato.com/ExternalView.aspx?type=1&no=20002IB토마토ko2026-11-02T19:12:52+09:00(리그테이블)10월 DCM 왕좌 되찾은 KB…ECM은 NH, 47억 차 1위https://www.ibtomato.com/ExternalView.aspx?type=1&no=20011IB토마토ko2026-11-02T17:49:51+09:00(크레딧시그널)케이뱅크, 사업자대출 키워도…수익성 제자리https://www.ibtomato.com/ExternalView.aspx?type=1&no=20006IB토마토ko2026-11-02T16:20:50+09:00(Deal클립)SK렌터카, 2년물에 쏠린 주문…금리 높여 2000억 차환https://www.ibtomato.com/ExternalView.aspx?type=1&no=20005IB토마토ko2026-11-02T16:14:18+09:00(IPO클립)동원파츠, IPO로 528억 확보…공장 짓고 빚 줄인다https://www.ibtomato.com/ExternalView.aspx?type=1&no=20003IB토마토ko2026-11-02T16:10:44+09:00롯데, 화학 체질 바꾸고 바이오·AI 키운다…성장축 재편https://www.ibtomato.com/ExternalView.aspx?type=1&no=20001IB토마토ko2026-11-02T09:04:33+09:00(부고)정연준(금호건설 재무본부 전무)씨 부친상https://www.ibtomato.com/ExternalView.aspx?type=1&no=19974IB토마토ko2026-10-29T17:01:48+09:00산업은행, 대기업 대출 36조 늘고 중소기업은 8조 줄고https://www.ibtomato.com/ExternalView.aspx?type=1&no=19968IB토마토ko2026-10-29T16:56:44+09:00(항공금융의 빈자리)①같은 기종, 비싼 임차료…항공사 '비용 족쇄'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19965IB토마토ko2026-10-29T16:10:05+09:00녹색채권, 규모가 가른 조달 실익…정부 지원도 변수https://www.ibtomato.com/ExternalView.aspx?type=1&no=19967IB토마토ko2026-10-29T15:35:48+09:00(럭셔리의 비극)③열 번 유찰·반값 낙찰…강남 하이엔드의 추락https://www.ibtomato.com/ExternalView.aspx?type=1&no=19969IB토마토ko2026-10-29T17:52:48+09:00케이아이엔엑스, 투자·배당 빼고 213억…쌓인 현금 어디로https://www.ibtomato.com/ExternalView.aspx?type=1&no=19966IB토마토ko2026-10-28T19:57:35+09:00우리투자증권, 첫 IPO부터 스팩…발기자금 87.5%가 '반값 CB'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19963IB토마토ko2026-10-28T19:39:37+09:00부광약품, 자회사 자산 줄고 임상비 200억…커지는 R&D 청구서https://www.ibtomato.com/ExternalView.aspx?type=1&no=19964IB토마토ko2026-10-28T19:02:58+09:00JB우리캐피탈, 지주가 넣는 2200억…배당으로 되돌아가나https://www.ibtomato.com/ExternalView.aspx?type=1&no=19962IB토마토ko2026-10-28T18:05:19+09:00삼성SDS, '올해 쓴다'던 1.2조는 예금에…왜 빌렸나https://www.ibtomato.com/ExternalView.aspx?type=1&no=19744IB토마토ko2026-10-28T06:00:00+09:00(IB&피플)백광현 법무법인 바른 변호사